Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces an update from Organon on the development of the drug candidate OG-6219, acquired by Organon through its acquisition of Forendo ...

Detailed price information for Standard Uranium Ltd (STND-X) from The Globe and Mail including charting and trades.